You Searched For "Pfizer antiviral" and got 19 results
Sort By:
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate Ameri…
Alex Morrell
Pfizer says that it may earn over $100 billion just by selling COVID-19 vaccine and antiviral pill
The rollout of the vaccine has already led to a substantial financial windfall for the New York …
Americans at risk of severe COVID-19 to receive free Pfizer antiviral pills after a positive test
"If you get COVID-19, the Pfizer pill reduces your chances of ending up in the hospital by 90%," Pr…
Dr. Catherine Schuster-Bruce
The first-ever COVID-19 pill may be just weeks away. A handful of other pills, inhalers, and nasal sprays also show promise.
Easy-to-take coronavirus treatments could complement vaccines. These are the most promising ones to…
Aria Bendix,Andrew Dunn
Why Pfizer's not worried about resistance to its new antiviral
These are Insider's biggest healthcare stories for November 8.
Leah Rosenbaum
The FDA has authorized pills to treat COVID-19, replenishing the tool kit of treatments against Omicron
The FDA on Thursday authorized Merck's antiviral pill, one day after authorizing Pfizer's pill.
Andrew Dunn,Allison DeAngelis
The 2 factors that will determine if Omicron is a true threat, according to Pfizer's top scientist
These are Insider's biggest healthcare stories for December 1.
Leah Rosenbaum
'An extraordinary effect': Pfizer says its COVID-19 pill reduced the risk of hospitalization and death by 89% in high-risk patients
"Our ability to stop living in fear is now within reach," Mikael Dolsten, Pfizer's chief scientific…
Andrew Dunn
What's ahead for COVID-19 treatments after Pfizer says its antiviral pill works
These are Insider's biggest healthcare stories for the week ending November 5.
Leah Rosenbaum
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
A COVID-19 pill could prevent infected people from getting seriously sick. But the FDA panel expres…
Andrew Dunn,Andrea Michelson
If President Joe Biden gets severely ill from COVID, then he'll have access to superior medical care including an army of doctors and his own medical suite
US presidents have access to some of the best medical care and doctors in the world, as well as acc…
Kimberly Leonard
Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out
The pill "significantly reduced the risk of hospitalization or death," according to the developers …
Marianne Guenot
Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it
The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…
Matthew Fox
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla Mozée
Merck jumps 10% as the drugmaker says its antiviral pill cuts the risk of hospitalizations and deaths in COVID patients
Merck already has a deal to supply 1.7 million courses of antiviral pill molnupiravir to the US gov…
Carla Mozée
Companies are racing to develop pills to treat COVID-19
These are Insider's biggest healthcare stories for the week ending October 1.
Leah Rosenbaum
A COVID-19 pill could soon fill a gap in our pandemic response that vaccines can’t overcome
Antivirals that can be taken orally are "one more piece of the larger puzzle of solving the COVID p…
Andrew Dunn
Pfizer CEO predicts 'constant waves' of COVID-19 because of complacency about the coronavirus and politicization of the pandemic
The consequences of people's hesitancy to wear masks and get vaccinated will likely be seen over th…
Grace Dean
Pfizer CEO is 'very confident' the company's oral COVID-19 pill will be effective against the new variant
"I'm very very confident that this drug works for all known mutations, including the Omicron one," …